Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield
- 1 January 1997
- journal article
- Published by Wiley in Transfusion
- Vol. 37 (1) , 79-85
- https://doi.org/10.1046/j.1537-2995.1997.37197176955.x
Abstract
Peripheral blood progenitor cells, harvested by apheresis after mobilization, provide rapid hematologic recovery after high-dose chemotherapy. However, because harvesting these cells is expensive and time-consuming, there has been much interest in optimizing collection protocols. An investigation was made to determine whether, in this clinical setting, peripheral blood progenitor cell yields may be predicted from preapheresis progenitor cell counts, allowing the length of each procedure to be "fine tuned" to achieve specific target goals. Preapheresis peripheral blood CD34+ cell and total colony-forming cell counts were assessed before 78 peripheral blood progenitor cell collections from 13 consecutive patients were performed. Preapheresis counts were correlated with actual progenitor cell yields. Factors affecting this correlation were analyzed. With the use of linear regression analysis preapheresis progenitor cell counts were found to correlate significantly but weakly with actual yields per kg of body weight per liter of blood processed (CD34+ cells: r = 0.43; colony-forming cells: r = 0.56). Further analysis revealed two possible causes: 1) circulating progenitor cell concentrations fluctuate widely during harvest, which implies that preapheresis counts are not representative of actual concentrations during apheresis, and 2) the efficiency with which apheresis machines extract mononuclear cells varies greatly between procedures. Preapheresis CD34+ and colony-forming cell counts correlated poorly with subsequent yields in this clinical setting, which suggests that it is not practical to use such counts to predict with certainty the length of apheresis needed to achieve a target yield.Keywords
This publication has 28 references indexed in Scilit:
- Optimizing dose and scheduling of filgrastim (granulocyte colony- stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers [see comments]Blood, 1995
- The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high‐dose chemotherapy supportTransfusion, 1995
- Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantationBlood, 1995
- CD34+ progenitors and colony‐forming units‐granulocyte macrophage are recruited during large‐volume leukapheresis and concentrated by counterflow centrifugal elutriationTransfusion, 1993
- Large‐volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignanciesTransfusion, 1992
- Defining a Therapeutic Dose of Peripheral Blood Stem CellsJournal of Hematotherapy, 1992
- Report on the European Workshop on Peripheral Blood Stem Cell Determination and Standardization—Mulhouse, France, February 6-8 and 14-15, 1992Journal of Hematotherapy, 1992
- Multiparameter flow-cytometrical quantitation of circulating CD34+-cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony-assayBritish Journal of Haematology, 1991
- QBEnd/10: A new immunostain for the routine diagnosis of Kaposi's sarcomaThe Journal of Pathology, 1990
- The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levelsJournal of Clinical Apheresis, 1986